Table 2.
Variables | 5-year OS | 5-year DFS | ||||
---|---|---|---|---|---|---|
Univariate | Multivariate | P | Univariate | Multivariate | P | |
P | HR (95% CI) | P | HR (95% CI) | |||
Age | 0.024 | 1.026 (1.005–1.047) | 0.014 | 0.011 | 0.979 (0.959–0.999) | 0.039 |
Sex (male) | 0.369 | 0.066 | ||||
BMI (kg/m2) | 0.307 | 0.326 | ||||
CEA | < 0.001 | 1.016 (1.007–1.026) | 0.001 | 0.058 | ||
ASA class | 0.053 | 0.669 | 0.032 | |||
Tumour location | 0.036 | 0.054 | 0.001 | 0.872 (0.802–0.948) | 0.001 | |
With robotic surgery | 0.925 | 0.451 | ||||
With previous abdominal surgery | 0.065 | 0.583 | ||||
Lymph nodes retrieved | 0.332 | 0.036 | 0.937 (0.888–0.989) | 0.018 | ||
TNM stage | 0.003 | 1.622 (1.068–2.464) | 0.023 | 0.001 | 1.919 (1.241–2.969) | 0.003 |
Differentiation grade | 0.010 | 1.664 (1.093–2.535) | 0.018 | < 0.001 | 1.660 (1.116–2.469) | 0.012 |
CRM (no involved) | 0.302 | 0.754 | ||||
With lymphovascular invasion | 0.018 | 0.123 | 0.005 |
Statistical analysis was performed using a multivariable Cox proportional hazards model. Significant variables from the univariate analysis were included in the multivariate Cox regression models to assess their contribution to 5-year OS and DFS. Variables with a P < 0.05 and hazard ratio (HR) > 20% were kept in the final model
Bold values indicate statistical significance
BMI body mass index, ASA American Society of Anesthesiologists, CRT chemoradiotherapy, TNM tumour node metastasis, CRM circumferential resection margin, OS overall survival, DFS disease-free survival, HR Hazard radio, 95% CI 95% confidence interval